...
机译:乙型肝炎病毒突变模式RTA181S + T184i + M204i可能有助于临床实践中的多药耐药性:分析大群患者
Chongqing Med Univ Dept Cell Biol &
Genet Mol Med &
Canc Res Ctr Chongqing 400016 Peoples R;
Chinese Peoples Liberat Army Gen Hosp Inst Infect Dis Med Ctr 5 Beijing 100039 Peoples R China;
Chinese Peoples Liberat Army Gen Hosp Inst Infect Dis Med Ctr 5 Beijing 100039 Peoples R China;
Chinese Peoples Liberat Army Gen Hosp Inst Infect Dis Med Ctr 5 Beijing 100039 Peoples R China;
Chinese Peoples Liberat Army Gen Hosp Inst Infect Dis Med Ctr 5 Beijing 100039 Peoples R China;
Chinese Peoples Liberat Army Gen Hosp Inst Infect Dis Med Ctr 5 Beijing 100039 Peoples R China;
Chinese Peoples Liberat Army Gen Hosp Inst Infect Dis Med Ctr 5 Beijing 100039 Peoples R China;
Chongqing Med Univ Dept Cell Biol &
Genet Mol Med &
Canc Res Ctr Chongqing 400016 Peoples R;
Chinese Peoples Liberat Army Gen Hosp Inst Infect Dis Med Ctr 5 Beijing 100039 Peoples R China;
Chongqing Med Univ Dept Cell Biol &
Genet Mol Med &
Canc Res Ctr Chongqing 400016 Peoples R;
Hepatitis B virus; Mutation; rtA181S+T184I+M204I; Multidrug-resistance; Adefovir; Entecavir;
机译:乙肝病毒突变模式rtL180M + A181C + M204V在临床实践中可能对恩替卡韦耐药
机译:基因型B基因型B与基因型C乙型肝炎病毒感染患者的耐药突变检测率和抗药性突变突变模式的比较
机译:基因型B基因型B与基因型C乙型肝炎病毒感染患者的耐药突变检测率和抗药性突变突变模式的比较
机译:含有马兜铃酸的草药和丙型肝炎病毒感染患者肝细胞癌的风险:台湾全国性人群研究
机译:在丙型肝炎病毒(免疫缺陷)合并感染的一组患者中,人类免疫缺陷病毒的发病机理。
机译:乙肝病毒突变模式rtL180M + A181C + M204V在临床实践中可能有助于恩替卡韦耐药
机译:乙型肝炎病毒突变模式RT180M + A181C + M204V可能有助于临床实践中的敌选抗性